Skip to main content
Fig. 5 | BMC Medical Imaging

Fig. 5

From: Comparison of 18F-sodium fluoride PET/CT, 18F-fluorocholine PET/CT and diffusion-weighted MRI for the detection of bone metastases in recurrent prostate cancer: a cost-effectiveness analysis in France

Fig. 5

Cost-effectiveness acceptability curves in Euros showing the results of probabilistic sensitivity analyses for each imaging modality. NaF = 18F-sodium fluoride PET/CT; FCH = 18F-fluorocholine PET/CT; DW-MRI = diffusion-weighted whole-body magnetic resonance imaging

Back to article page

BMC Medical Imaging

ISSN: 1471-2342

Contact us